Related Experiment Video

Updated: May 24, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Deregulated hepatic metabolism exacerbates impaired testosterone production in Mrp4-deficient mice

Jessica A Morgan1, Satish B Cheepala, Yao Wang

  • 1Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

The Journal of Biological Chemistry
|March 1, 2012
PubMed

Insights

Multidrug resistance protein 4 (Mrp4) is essential for testicular testosterone production and gametogenesis by maintaining Leydig cell cAMP homeostasis. Disruption of Mrp4 impairs testosterone synthesis, impacting reproductive health.

Area of Science:

  • Reproductive Biology
  • Molecular Endocrinology
  • Cell Physiology

Background:

  • The function of multidrug resistance protein 4 (Mrp4, Abcc4) in testicular physiology remains largely unknown.
  • Mrp4 is expressed in Leydig cells, which are crucial for testosterone production.
  • Testosterone synthesis is regulated by intracellular cyclic adenosine monophosphate (cAMP) levels, influenced by luteinizing hormone (LH) signaling.

Purpose of the Study:

  • To elucidate the physiological role of Mrp4 in mouse and human Leydig cells.
  • To investigate the impact of Mrp4 deficiency on testosterone production and gametogenesis.
  • To determine the molecular mechanisms by which Mrp4 influences Leydig cell function and cAMP homeostasis.

Main Methods:

  • Comparative analysis of Mrp4 knockout (Mrp4(-/-)) and wild-type (Mrp4(+/+)) mice.
  • Assessment of testicular testosterone levels, gametogenesis, and Leydig cell cAMP homeostasis.
  • In vitro studies using primary Leydig cells to evaluate cAMP production, CREB phosphorylation, and gene expression following LH stimulation.

Main Results:

  • Young Mrp4(-/-) mice exhibited impaired gametogenesis, reduced testicular testosterone, and disrupted Leydig cell cAMP homeostasis.
  • LH-stimulated cAMP production and CREB phosphorylation were attenuated in Mrp4(-/-) Leydig cells.
  • Expression of testosterone biosynthesis genes was reduced in Mrp4(-/-) Leydig cells, confirming Mrp4's requirement for normal testosterone production.
  • Adult Mrp4(-/-) mice were fertile, despite impaired testicular testosterone production, due to compensatory upregulation of hepatic testosterone metabolism.

Conclusions:

  • Mrp4 is indispensable for maintaining normal Leydig cell function and testosterone biosynthesis.
  • Disruption of Mrp4 leads to testicular dysfunction and impaired gametogenesis, potentially through dysregulation of cAMP signaling.
  • These findings highlight the critical role of Mrp4 in male reproductive health and have implications for drug-induced side effects on androgen production.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...